ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
3.835
-0.165 (-4.13%)
At close: Jan 30, 2026, 4:00 PM EST
3.800
-0.035 (-0.91%)
After-hours: Jan 30, 2026, 6:03 PM EST

ENDRA Life Sciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-8.01-11.51-10.06-13.18-11.23-11.73
Depreciation & Amortization
0.160.210.280.230.220.17
Other Amortization
-----0.23
Asset Writedown & Restructuring Costs
-0.010.0200.01-
Stock-Based Compensation
0.420.5711.21.442.1
Other Operating Activities
2.073.190.14--0.31-
Change in Inventory
0.330.24-0.12-1.36-0.69-0.48
Change in Accounts Payable
0.04-0.2-0.820.110.49-0.83
Change in Other Net Operating Assets
-0.10.10.020.22-1.06-0.21
Operating Cash Flow
-5.09-7.4-9.55-12.77-11.12-10.75
Capital Expenditures
-0.02-0.02-0.03-0.2-0.05-0.08
Sale of Property, Plant & Equipment
-00.01---
Investing Cash Flow
-0.02-0.01-0.02-0.2-0.05-0.08
Long-Term Debt Issued
-----0.34
Total Debt Issued
-----0.34
Long-Term Debt Repaid
--0.03----
Total Debt Repaid
--0.03----
Net Debt Issued (Repaid)
--0.03---0.34
Issuance of Common Stock
-1.156.488.413.411.54
Other Financing Activities
5.376.691.03---
Financing Cash Flow
1.157.817.528.413.411.88
Miscellaneous Cash Flow Adjustments
-0-0----
Net Cash Flow
-3.950.4-2.06-4.572.231.05
Free Cash Flow
-5.1-7.42-9.58-12.97-11.17-10.82
Free Cash Flow Per Share
-7.92-36.70----
Cash Interest Paid
0.050.030.040.060.060
Levered Free Cash Flow
-4.49-6.22-5.86-4.78-6.75-6.39
Unlevered Free Cash Flow
-4.49-6.22-5.86-4.78-6.75-6.47
Change in Working Capital
0.270.13-0.92-1.03-1.26-1.52
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q